AACHEN, Germany, Oct. 22, 2024 /PRNewswire/ -- Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable...
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Seaking AlphaSeeking Alpha / Seaking Alpha 2 hours ago 1 Views
Comments